# OnCo record paper-keynote-426-nejm-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-keynote-426-nejm-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-keynote-426-nejm-2019" ;
  schema:name "KEYNOTE-426: pembrolizumab plus axitinib versus sunitinib for advanced renal cell carcinoma"@en ;
  schema:description "Combining pembrolizumab with the kinase inhibitor axitinib lengthened survival and delayed progression compared with sunitinib as first treatment for advanced clear cell kidney cancer, across all risk groups."@en ;
  schema:url <https://onco.cc/key-papers/paper-keynote-426-nejm-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1816714>, <https://pubmed.ncbi.nlm.nih.gov/30779529/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1816714> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Rini BI, Plimack ER, Stus V, et al." ;
  onco:cancers <https://onco.cc/cancers/clear-cell-rcc/> ;
  onco:drugs <https://onco.cc/drugs/axitinib/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/sunitinib/> ;
  onco:trials <https://onco.cc/trials/keynote-426/> ;
  onco:journals <https://onco.cc/journals/nejm/> .